{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:45:28Z","timestamp":1789098328605,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T00:00:00Z","timestamp":1468022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The study was funded by EMD Serono, a business of Merck KGaA, Darmstadt, Germany"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1128-2","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T19:31:45Z","timestamp":1468006305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial"],"prefix":"10.1186","volume":"17","author":[{"given":"Frank W.","family":"Roemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lohmander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel D.","family":"Crema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Dias","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Muurahainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Felson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Guermazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,9]]},"reference":[{"key":"1128_CR1","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","volume":"162","author":"K Pavelk\u00e1","year":"2002","unstructured":"Pavelk\u00e1 K, Gatterov\u00e1 J, Olejarov\u00e1 M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162:2113\u201323.","journal-title":"Arch Intern Med"},{"key":"1128_CR2","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.21122","volume":"52","author":"KD Brandt","year":"2005","unstructured":"Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 2005;52:2015\u201325.","journal-title":"Arthritis Rheum"},{"key":"1128_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","volume":"72","author":"JY Reginster","year":"2013","unstructured":"Reginster JY, Badurski J, Bellamy N, Bensen W, Chapurlat R, Chevalier X, et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis. 2013;72:179\u201386.","journal-title":"Ann Rheum Dis"},{"key":"1128_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/annrheumdis-2012-202239","volume":"72","author":"H Graverand MP le","year":"2013","unstructured":"le Graverand MP H, Clemmer RS, Redifer P, Brunell RM, Hayes CW, Brandt KD, et al. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2013;72:187\u201395.","journal-title":"Ann Rheum Dis"},{"key":"1128_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2010.178","volume":"7","author":"DJ Hunter","year":"2011","unstructured":"Hunter DJ. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat Rev Rheumatol. 2011;7:13\u201322.","journal-title":"Nat Rev Rheumatol"},{"key":"1128_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1053\/joca.2002.0514","volume":"10","author":"JL Ellsworth","year":"2002","unstructured":"Ellsworth JL, Berry J, Bukowski T, Claus J, Feldhaus A, Holderman S, et al. Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartilage. 2002;10:308\u201320.","journal-title":"Osteoarthritis Cartilage"},{"key":"1128_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.joca.2005.03.003","volume":"13","author":"EE Moore","year":"2005","unstructured":"Moore EE, Bendele AM, Thompson DL, Littau A, Waggie KS, Reardon B, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage. 2005;13:623\u201331.","journal-title":"Osteoarthritis Cartilage"},{"key":"1128_CR8","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/art.38614","volume":"66","author":"LS Lohmander","year":"2014","unstructured":"Lohmander LS, Hellot S, Dreher D, Krantz EF, Kruger DS, Guermazi A, et al. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66:1820\u201331.","journal-title":"Arthritis Rheumatol"},{"key":"1128_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/annrheumdis-2012-201810","volume":"72","author":"FW Roemer","year":"2013","unstructured":"Roemer FW, Felson DT, Wang K, Crema MD, Neogi T, Zhang Y, et al. Co-localisation of non-cartilaginous articular pathology increases risk of cartilage loss in the tibiofemoral joint--the MOST study. Ann Rheum Dis. 2013;72:942\u201348.","journal-title":"Ann Rheum Dis"},{"key":"1128_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494\u2013502.","journal-title":"Ann Rheum Dis"},{"key":"1128_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/art.39265","author":"F Eckstein","year":"2015","unstructured":"Eckstein F, Wirth W, Guermazi A, Maschek S, Aydemir A. Intra-articular sprifermin not only increases cartilage thickness, but also reduces cartilage loss - location-independent post hoc analysis using MR imaging. Arthritis Rheumatol. 2015. doi:\n                    10.1002\/art.39265\n                    \n                   [Epub ahead of print].","journal-title":"Arthritis Rheumatol"},{"key":"1128_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.joca.2003.11.003","volume":"12","author":"CG Peterfy","year":"2004","unstructured":"Peterfy CG, Guermazi A, Zaim S, Tirman PF, Miaux Y, White D, et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage. 2004;12:177\u201390.","journal-title":"Osteoarthritis Cartilage"},{"key":"1128_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/art.21724","volume":"54","author":"DJ Hunter","year":"2006","unstructured":"Hunter DJ, Zhang YQ, Niu JB, Tu X, Amin S, Clancy M, et al. The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum. 2006;54:795\u2013801.","journal-title":"Arthritis Rheum"},{"key":"1128_CR14","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1002\/art.22016","volume":"54","author":"DJ Hunter","year":"2006","unstructured":"Hunter DJ, Zhang YQ, Tu X, Lavalley M, Niu JB, Amin S, et al. Change in joint space width: hyaline articular cartilage loss or alteration in meniscus? Arthritis Rheum. 2006;54:2488\u201395.","journal-title":"Arthritis Rheum"},{"key":"1128_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/ard.2008.088732","volume":"68","author":"JP Raynauld","year":"2009","unstructured":"Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis. 2009;68:938\u201347.","journal-title":"Ann Rheum Dis"},{"key":"1128_CR16","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/ard.2010.140848","volume":"70","author":"LM Wildi","year":"2011","unstructured":"Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6\u00a0months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis. 2011;70:982\u201389.","journal-title":"Ann Rheum Dis"},{"key":"1128_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.joca.2012.09.012","volume":"21","author":"DT Felson","year":"2013","unstructured":"Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013;21:10\u20135.","journal-title":"Osteoarthritis Cartilage"},{"key":"1128_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/ard.2008.096834","volume":"68","author":"FW Roemer","year":"2009","unstructured":"Roemer FW, Guermazi A, Javaid MK, Lynch JA, Niu J, Zhang Y, et al. Change in MRI-Detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicenter study of knee osteoarthritis. Ann Rheum Dis. 2009;68:1461\u201365.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-016-1128-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1128-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T17:58:12Z","timestamp":1487699892000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,9]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1128-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,9]]},"article-number":"267"}}